Chong Y. Tan

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Enzyme replacement therapy compared with best supportive care for the treatment of Pompe Disease: a systematic review and network meta-analysis.

Enzyme replacement therapy compared with best supportive care for the treatment of Pompe Disease: a systematic review and network meta-analysis.

Journal: Health technology assessment (Winchester, England)

Published: February 16, 2026

Correction: Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes.

Correction: Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes.

Journal: Orphanet journal of rare diseases

Published: November 18, 2025

Multimodal phenotypic clustering predicts cardiac outcomes in Fabry disease.

Multimodal phenotypic clustering predicts cardiac outcomes in Fabry disease.

Journal: Orphanet journal of rare diseases

Published: August 15, 2025

Re-anchoring the Value of Innovative Therapies in NICE Decision Making When Comparators are Cost Ineffective: A Case Study of Late-Onset Pompe Disease.

Re-anchoring the Value of Innovative Therapies in NICE Decision Making When Comparators are Cost Ineffective: A Case Study of Late-Onset Pompe Disease.

Journal: PharmacoEconomics

Published: July 30, 2025

Enzyme replacement therapy for the treatment of late onset Pompe disease: A systematic review and network meta-analysis.

Enzyme replacement therapy for the treatment of late onset Pompe disease: A systematic review and network meta-analysis.

Journal: Orphanet journal of rare diseases

Published: March 29, 2025

The cost-effectiveness of enzyme replacement therapies versus best supportive care for treating late onset Pompe disease in the UK NHS.

The cost-effectiveness of enzyme replacement therapies versus best supportive care for treating late onset Pompe disease in the UK NHS.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: March 29, 2025

Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes.

Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes.

Journal: Orphanet journal of rare diseases

Published: November 18, 2024

The management and clinical outcomes of pregnancies in women with urea cycle disorders: A review of the literature and results of an international survey.

The management and clinical outcomes of pregnancies in women with urea cycle disorders: A review of the literature and results of an international survey.

Journal: Journal of inherited metabolic disease

Published: July 17, 2023

A case of mesenteric panniculitis in a patient with Tangier disease.

A case of mesenteric panniculitis in a patient with Tangier disease.

Journal: Journal of clinical lipidology

Published: June 29, 2021

In-depth phenotyping for clinical stratification of Gaucher disease.

In-depth phenotyping for clinical stratification of Gaucher disease.

Journal: Orphanet journal of rare diseases

Published: May 22, 2021

Eye movement biomarkers allow for the definition of phenotypes in Gaucher Disease.

Eye movement biomarkers allow for the definition of phenotypes in Gaucher Disease.

Journal: Orphanet journal of rare diseases

Published: June 21, 2020

Mechanistic convergence and shared therapeutic targets in Niemann-Pick disease.

Mechanistic convergence and shared therapeutic targets in Niemann-Pick disease.

Journal: Journal of inherited metabolic disease

Published: September 10, 2019

Showing 1-12 of 21

Last Updated: 09/26/2026